The pharmaceutical markets in Russia, the Eurasian Union and the CIS are of growing commercial importance and companies looking to take advantage of the opportunities available need to be fully up to date with the evolving regulatory landscape for human pharmaceuticals, including the potential for market access offered by the latest legislation.
This interactive course will guide you through national procedures as well as explore the implications of and updates on the Eurasian Union regulation.
The focus of the programme is to offer practical advice in developing your regulatory strategy for product approval in these countries and you will get the full benefit of our trainer’s experience and expertise in the region.
Benefits of attending:
- Understand the competitive landscape of the growing markets in the CIS region
- Discover the essential information on the latest regulations and registration procedures in the Eurasian Customs Union
- Discuss national requirements and guidance for drug approval in the core CIS markets of Russia, Kazakhstan, Belarus, Ukraine and Azerbaijan
- Develop your CIS regional submission plan and place it within your global regulatory strategy
- Gain practical advice from an industry expert working in the CIS region
Why you should attend
Attending this programme will:
- Give you the full background to the CIS pharmaceutical market
- Ensure that you understand all the implications of the latest regulations which will affect how you do business in the Eurasian Economic Union (EAEU)
- Help clarify the document requirements and timelines of national procedures and EAEU registration procedures
- Update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries
Certifications:
- CPD: 12 hours for your records
- Certificate of completion
Course Content
Day 1
